封面
市場調查報告書
商品編碼
2058304

陣列市場:按類型、最終用戶和地區分類

Array Market, By Type, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 153 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2026 年,陣列(生命科學和生技設備)市場規模將達到 114 億美元,到 2033 年將達到 311 億美元。預計從 2026 年到 2033 年,其複合年成長率將達到 15.4%。

報告範圍 報告詳情
基準年: 2025 2026年市場規模: 114億美元
歷史數據時期: 2020年至2024年 預測期: 2026年至2033年
2026年至2033年預測期間的複合年成長率: 15.40% 2033年市場規模預測: 311億美元

DNA微陣列(或稱為晶片)是一種半導體表面,其上結合多種基因序列作為探針。 DNA微陣列用於識別基因組不同區域的基因型,或同時評估多個基因的表達量。這項技術在臨床診斷、農業和環境管理等領域都有應用。微陣列或生物晶片通常是實驗室顯微鏡載玻片,由玻璃、矽晶片或尼龍膜製成。它們是2D(有時是3D)陣列,指定分佈著數千個微孔。

市場動態

微陣列技術結合了生物資訊和生物資訊學見解,為許多生物系統帶來了新的視角,並在癌症研究領域中得到了最廣泛的應用。微陣列能夠測量樣本中mRNA轉錄物的水平,由於陣列上可以放置數千個基因片段,因此可以提供癌症中基因表現的全基因組整體情況。由此可見,癌症發生率的不斷上升預計將在預測期內推動市場成長。例如,根據全球癌症發生率和死亡率資料庫Globocan於2021年2月發布的報告,2020年全球報告了1,930萬例新增癌症病例。女性乳癌超過肺癌,成為最常見的癌症,2020年全球確診新病例估計為230萬例,其次是肺癌、大腸癌、攝護腺癌和胃腸癌。

此外,根據美國疾病管制與預防中心(CDC)的數據,2020 年美國新增癌症病例 1,603,844 例,癌症死亡人數 602,347 人。

本次調查的主要特點

  • 本研究揭示了各個細分市場的潛在商機,並為該市場說明了一個具有吸引力的投資提案矩陣。
  • 此外,本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
  • 本研究根據以下參數創建了全球陣列市場(生命科學和生物技術儀器)主要公司的概況:公司亮點、產品系列、關鍵亮點、財務績效和策略。
  • 透過利用本報告中的見解,企業行銷負責人和經營團隊將能夠就未來的產品發布、型號升級、市場擴張和行銷策略做出明智的決策。
  • 全球陣列市場(生命科學和生物技術設備)報告針對該行業的各種相關人員,包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
  • 相關人員可以透過利用各種策略矩陣來簡化決策過程,這些矩陣用於分析全球陣列市場(生命科學和生物技術儀器)。

目錄

第1章:研究目標與前提條件

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場概覽

  • 報告說明
    • 市場定義和範圍
  • 執行摘要

第3章:市場動態、監管與趨勢分析

  • 市場動態
  • 影響分析
  • 主要亮點
  • 監管趨勢
  • 產品上市及核准
  • PEST分析
  • 波特的分析
  • 市場機遇
  • 監管趨勢
  • 主要進展
  • 產業趨勢

第4章 全球陣列市場(生命科學和生物技術儀器),按類型分類,2021-2033年

  • DNA晶片
  • 蛋白質陣列
  • 組織陣列
  • 細胞陣列
  • 其他(肽陣列及其他)

第5章:全球陣列市場(生命科學和生物技術儀器),按最終用戶分類,2021-2033年

  • 生物製藥和製藥公司
  • 診斷檢查室
  • 研究所
  • 其他(學術機構等)

第6章 全球陣列市場(生命科學和生物技術儀器),按地區分類,2021-2033年

  • 北美洲
    • 介紹
    • 市場規模及預測:依類型
    • 市場規模及預測:依最終用戶分類
  • 美國
  • 加拿大
  • 拉丁美洲
    • 介紹
    • 市場規模及預測:依類型
    • 市場規模及預測:依最終用戶分類
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲國家
  • 歐洲
    • 介紹
    • 市場規模及預測:依類型
    • 市場規模及預測:依最終用戶分類
  • 德國
  • 英國
  • 西班牙
  • 法國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
    • 介紹
    • 市場規模及預測:依類型
    • 市場規模及預測:依最終用戶分類
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • ASEAN
  • 其他亞太國家
  • 中東
    • 介紹
    • 市場規模及預測:依類型
    • 市場規模及預測:依最終用戶分類
  • 海灣合作理事會國家
  • 以色列
  • 其他中東國家
  • 非洲
    • 介紹
    • 市場規模及預測:依類型
    • 市場規模及預測:依最終用戶分類
  • 南非
  • 北非
  • 中非

第7章 競爭情勢

  • Thermo Fisher Scientific Inc.
  • Illumina, Inc.
  • Roche Diagnostics Nederland BV,
  • Bio-Rad Laboratories, Inc.
  • Life Technologies
  • Caliper Life Sciences
  • Perkin Elmer, Inc.
  • Siemens Healthineers
  • Agilent Technologies Inc.
  • PathogenDx, Inc.
  • Twist Bioscience Corporation
  • Arraylt Corporation
  • Molecular Device, LLC
  • Raybiotech Inc.

第8章 分析師建議

  • 機會分析
  • 分析師意見
  • Coherent Opportunity Map

第9章 參考文獻與調查方法

  • 參考
  • 調查方法
  • 關於本公司
簡介目錄
Product Code: CMI4221

Array Market (Life Science and Biotechnology Instruments) is estimated to be valued at USD 11.4 Bn in 2026 and is expected to reach USD 31.1 Bn by 2033, growing at a compound annual growth rate (CAGR) of 15.4% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 11.4 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 15.40% 2033 Value Projection: USD 31.1 Bn

A DNA microarray or chip is a semiconductor surface on which sequences of many varied genes are bonded to probes. DNA microarrays are used to genotype different areas of a genome or to assess the expression levels of several genes at once. The method is applicable to areas such as clinical diagnostics, agriculture, environmental management, and other fields. A microarray or biochip is a lab-oriented microscope slide that is usually made of glass, a silicon chip, or a nylon membrane. It is a 2D array (sometimes 3D) whose surface is provided with thousands of minute pores in defined positions.

Market Dynamics

Microarrays leverage biological information with bioinformatics knowledge to bring new insights to many biological systems and have been applied most intensively to the field of cancer research. A microarray, therefore, measures the levels of mRNA transcripts in a sample, and since thousands of gene fragments can be located on an array, it can provide a genome-wide view of gene expression in cancer. Thus, the increasing prevalence of cancer is expected to foster market growth over the forecast period. For instance, In February 2021, according to the report published by Globocan, a worldwide database of cancer incidence and mortality rates, 19.3 million new cancer cases were reported worldwide in 2020. Female breast cancer had surpassed lung cancer as the most commonly diagnosed cancer, with an estimated 2.3 million new cases globally in 2020, followed by lung, colorectal, prostate, and stomach cancers.

Furthermore, According to the Centers for Disease Control and Prevention, there were 1,603,844 new cancer cases and 602,347 people who died of cancer in the U.S. in 2020

Key features of the study

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global array market (life science and biotechnology instruments) based on the following parameters-Company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Illumina, Inc., Roche Diagnostics Nederland B.V., Bio-Rad Laboratories, Inc., Life Technologies, Caliper Life Sciences, Perkin Elmer, Inc., Siemens Healthineers, Agilent Technologies Inc., PathogenDx, Inc., Twist Bioscience Corporation, Arraylt Corporation, Molecular Device, LLC and Raybiotech Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global array market (life science and biotechnology instruments)report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global array market (life science and biotechnology instruments)

Market Segmentation

  • By Type (Revenue, USD Bn, 2021-2033)
    • DNA Array
    • Protein Array
    • Tissue Array
    • Cell Array
    • Others (Peptide Array and Others)
  • By End user (Revenue, USD Bn, 2021-2033)
    • Biopharmaceutical and Pharmaceutical Companies
    • Diagnostic Laboratories
    • Research Laboratories
    • Others (Academic Institutes and among Others)
  • By Region (Revenue, USD Bn, 2021-2033)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • Central Africa
    • North Africa
  • Key Players
    • Thermo Fisher Scientific Inc.
    • Illumina, Inc.
    • Roche Diagnostics Nederland B.V.
    • Bio-Rad Laboratories, Inc.
    • Life Technologies
    • Caliper Life Sciences
    • Perkin Elmer, Inc.
    • Siemens Healthineers
    • Agilent Technologies Inc.
    • PathogenDx, Inc.
    • Twist Bioscience Corporation
    • Arraylt Corporation
    • Molecular Device, LLC
    • Raybiotech Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Overview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Array Market (Life Science and Biotechnology Instruments), By Type
    • Global Array Market (Life Science and Biotechnology Instruments), By End User

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Market Opportunities
  • Regulatory Scenario
  • Key Developments
  • Industry Trend

4. Global Array Market (Life Science and Biotechnology Instruments), By Type, 2021-2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • DNA Array
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Protein Array
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Tissue Array
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Cell Array
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Others (Peptide Array and Others)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

5. Global Array Market (Life Science and Biotechnology Instruments), By End User, 2021-2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Biopharmaceutical and Pharmaceutical Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Diagnostic Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Research Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Others (Academic Institutes and among Others)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

6. Global Array Market (Life Science and Biotechnology Instruments), By Region, 2021 - 2033, Value (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2026 & 2033, Value (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • U.S.
  • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • South Africa
  • North Africa
  • Central Africa

7. Competitive Landscape

  • Thermo Fisher Scientific Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Illumina, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Roche Diagnostics Nederland B.V.,
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Bio-Rad Laboratories, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Life Technologies
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Caliper Life Sciences
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Perkin Elmer, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Siemens Healthineers
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Agilent Technologies Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • PathogenDx, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Twist Bioscience Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Arraylt Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Molecular Device, LLC
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Raybiotech Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

8. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

9. References and Research Methodology

  • References
  • Research Methodology
  • About us